![Mondher Mahjoubi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mondher Mahjoubi
Corporate Officer/Principal bij
GSK PLC
Profiel
Mondher Mahjoubi is currently Chairman at PDC Line Pharma SASU, Member at the American Society of Clinical Oncology, Inc., Member at the European Society for Medical Oncology, and will be Chief Patient Officer at GSK Plc starting in 2026.
Formerly, Dr. Mahjoubi was Chairman-Executive Board & Chief Executive Officer at Innate Pharma SA from 2016 to 2024, Senior Vice President-Global Product Strategy at Genentech, Inc. from 2010 to 2013, and Senior VP-Global Product Strategy at AstraZeneca PLC from 2015 to 2017.
Education includes graduate studies at the University of Tunis.
Actieve functies van Mondher Mahjoubi
| Bedrijven | Functie | Begin |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01-01-2026 |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
PDC Line Pharma SASU
 PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology Develops plasmacytoid dendritic cells loaded with cancer antigens | Voorzitter | - |
Eerdere bekende functies van Mondher Mahjoubi
| Bedrijven | Functie | Einde |
|---|---|---|
| INNATE PHARMA | Algemeen Directeur | 01-01-2024 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 13-01-2017 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01-01-2013 |
Opleiding van Mondher Mahjoubi
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
87
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
University of Tunis
 University of Tunis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDC Line Pharma SASU
PDC Line Pharma SASU Pharmaceuticals: MajorHealth Technology Develops plasmacytoid dendritic cells loaded with cancer antigens | Health Technology |
